Rusciano D, Lorenzoni P, Burger M M
Friedrich Miescher Institute, Basel, Switzerland.
Int J Cancer. 1991 May 30;48(3):450-6. doi: 10.1002/ijc.2910480324.
Unselected F9 murine embryonal carcinoma cells preferentially colonize the liver upon injection into tail veins of syngeneic mice, while the lungs are only very rarely colonized. Here we show that F9 cells attach better to fibronectin than to laminin in an adhesion assay, like other liver-colonizing cell lines. Moreover, assays of adhesion to extracellular matrix (ECM) prepared from rat organs (liver, lung and kidney) demonstrate that, in the absence of serum, F9 cells adhere better to liver- than to kidney- or lung-derived ECM. Even in the presence of FCS, the adhesion to lung ECM remains very low. This very low adhesiveness of F9 cells to lung-derived ECM correlates well with the finding that, in an organ distribution assay, tail-vein-injected F9 cells are very rapidly released from the lungs, when compared to the retention times of the lung-specific murine melanoma cell line B16-F10. Yet another property appears to contribute to organ-specific colonization of these cells: extracts of liver promote the growth of F9 cells, in contrast to extracts of lung or kidney which have no effect. These data suggest that preferential formation of metastases in the liver following the intravenous injection of F9 cells is the result of both their adhesive abilities and their growth response to local microenvironment.
未筛选的F9小鼠胚胎癌细胞经尾静脉注射到同基因小鼠体内后,优先在肝脏中定植,而肺部很少被定植。在这里我们发现,在黏附试验中,F9细胞与纤连蛋白的黏附能力强于层粘连蛋白,这与其他在肝脏定植的细胞系情况类似。此外,对从大鼠器官(肝脏、肺和肾脏)制备的细胞外基质(ECM)进行的黏附试验表明,在无血清条件下,F9细胞与肝脏来源的ECM的黏附能力强于肾脏或肺来源的ECM。即使在有胎牛血清(FCS)存在的情况下,F9细胞与肺ECM的黏附能力仍然很低。F9细胞与肺来源的ECM的这种极低黏附性,与以下发现密切相关:在器官分布试验中,与肺特异性小鼠黑色素瘤细胞系B16-F10的滞留时间相比,经尾静脉注射的F9细胞能非常迅速地从肺部清除。这些细胞的器官特异性定植似乎还有另一个原因:肝脏提取物能促进F9细胞的生长,而肺或肾脏提取物则无此作用。这些数据表明,静脉注射F9细胞后,肝脏中优先形成转移灶是其黏附能力和对局部微环境生长反应共同作用的结果。